scholarly journals Impermeable and Compliant: SIBS as a Promising Encapsulant for Ionically Electroactive Devices

Robotics ◽  
2019 ◽  
Vol 8 (3) ◽  
pp. 60 ◽  
Author(s):  
Ebrahimi Takalloo ◽  
Fannir ◽  
Nguyen ◽  
Plesse ◽  
Vidal ◽  
...  
Keyword(s):  
Polyethylene Oxide ◽  
Polymer Network ◽  
Thermoplastic Elastomer ◽  
Butadiene Rubber ◽  
Promising Candidate ◽  
Drying Time ◽  
Fda Approval ◽  
Electrochemical Devices ◽  
Ionic Devices

Metals and glass are excellent for containing electrolytes and liquids in general, but their rigid mechanics limits their application for mechanically active ionic actuators or flexible/ stretchable electrochemical devices such as batteries and supercapacitors. In this study, we evaluate the performance of spray-coated poly (styrene-block-isobutylene-block-styrene) (SIBS) as a stretchable encapsulant, which suggests that it offers a better combination of compliance and impermeability than any other barrier. We examined the drying time of 360-µm thick encapsulated tri-layer conducting polymer (CP) actuators, comprised of poly(3,4-Ethylenedioxythiophene) (PEDOT) as the CP electrode and an interpenetrated polymer network of polyethylene oxide (PEO) and nitrile butadiene rubber (NBR) as the separator layer, which operates with a 1 M solution of Lithium bis(trifluoromethanesulfonyl)imide (Li+TFSI−) in propylene carbonate (PC). A 100-µm thick SIBS encapsulation layer is anticipated to help these devices to retain 80% of stored PC for more than 1000 times longer compared to when there is no encapsulation (from less than 0.5 days to over 1.5 years). This low permeability combined with the low Young’s modulus of the SIBS film, its biocompatibility, biostability, and FDA approval, as well as ease of fabrication, make this thermoplastic elastomer a promising candidate as an encapsulant for flexible ionic devices such as flexible batteries and supercapacitors, ionic-electrode capacitive sensors, and ionically electroactive actuators. This paves the way for using these devices in implantable and in vivo applications.

An octahedral stress-based fracture criterion for hyperelastic materials

2020 ◽  
pp. 095440622097213
Author(s):  
A Hamdi ◽  
A Boulenouar ◽  
N Benseddiq
Keyword(s):  
Pure Shear ◽  
Thermoplastic Elastomer ◽  
Styrene Butadiene Rubber ◽  
Butadiene Rubber ◽  
Principal Stresses ◽  
Hyperelastic Materials ◽  
Biaxial Tests ◽  
Set Up ◽  
Loading Modes ◽  
Styrene Butadiene

No unified stress-based criterion exists, in the literature, for predicting the rupture of hyperelastic materials subjected to mutiaxial loading paths. This paper aims to establish a generalized rupture criterion under plane stress loading for elastomers. First, the experimental set up, at breaking, including various loading modes, is briefly described and commented. It consists of uniaxial tests, biaxial tests and pure shear tests, performed on different rubbers. The used vulcanizate and thermoplastic rubber materials are a Natural Rubber (NR), a Styrene Butadiene Rubber (SBR), a Polyurethane (PU) and a Thermoplastic elastomer (TPE). Then, we have investigated a new theoretical approach, based upon the principal stresses, to establish a failure criterion under quasi-static loadings. Thus, we have proposed a new analytical model expressed as a function of octahedral stresses. Quite good agreement is highlighted when comparing the ultimate stresses, at break, between the experimental data and the prediction of the proposed criteria using our rubber-like materials.

scholarly journals Preclinical Pharmacokinetics of C118P, a Novel Prodrug of Microtubules Inhibitor and Its Metabolite C118 in Mice, Rats, and Dogs

Molecules ◽  
2018 ◽  
Vol 23 (11) ◽  
pp. 2883 ◽  
Author(s):  
Cang Zhang ◽  
Xiaolan Zhang ◽  
Guangji Wang ◽  
Ying Peng ◽  
Xueyuan Zhang ◽  
...  
Keyword(s):  
Clinical Development ◽  
High Dose ◽  
Protein Inhibitor ◽  
Promising Candidate ◽  
Preclinical Pharmacokinetics ◽  
Tumor Bearing ◽  
Microtubule Protein ◽  
Further Development

C118P, a phosphate prodrug of C118, which is a novel microtubule protein inhibitor, is currently under Phase I clinical development in China for treating ovarian cancer and lung cancer. The preclinical pharmacokinetics of prodrug C118P and its metabolite C118 were extensively characterized in vivo in mice, rats, and dogs and in vitro to support the further development of C118P. The preclinical tissue distribution and excretion were investigated in rats. Plasma protein binding in mice, rat, and human, and hepatic microsomal metabolic stability in mice, rat, dog, monkey, and human, were also evaluated. The (AUC0-inf) and C30s of C118P at 50 mg/kg in rats and 6 mg/kg in dogs, and the C2min of C118 at 6 mg/kg in dogs increased less than the dosage increase, suggested nonlinear pharmacokinetic occurred at high dose. As a prodrug, C118P can be quickly hydrolyzed into C118 after an intravenous administration. The unbound C118 in plasma is slightly higher than C118P. C118P can hardly penetrate the tissue, while C118 can distribute widely into tissues. In tumor-bearing nude mice, the concentration of C118 is high in lung, ovary, and tumor, with an extended half-life in tumor. C118P is a promising candidate prodrug for further clinical development.

scholarly journals Radiosynthesis,In VivoBiological Evaluation, and Imaging of Brain Lesions with [123I]-CLINME, a New SPECT Tracer for the Translocator Protein

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
F. Mattner ◽  
M. Quinlivan ◽  
I. Greguric ◽  
T. Pham ◽  
X. Liu ◽  
...  
Keyword(s):  
Radiochemical Yield ◽  
Brain Lesions ◽  
Spect Imaging ◽  
Translocator Protein ◽  
Promising Candidate ◽  
The Mean ◽  
Iodine 123 ◽  
Excitotoxic Lesion ◽  
Tspo Expression

The high affinity translocator protein (TSPO) ligand 6-chloro-2-(4′-iodophenyl)-3-(N,N-methylethyl)imidazo[1,2-a]pyridine-3-acetamide (CLINME) was radiolabelled with iodine-123 and assessed for its sensitivity for the TSPO in rodents. Moreover neuroinflammatory changes on a unilateral excitotoxic lesion rat model were detected using SPECT imaging. [123I]-CLINME was prepared in 70–80% radiochemical yield. The uptake of [123I]-CLINME was evaluated in rats by biodistribution, competition, and metabolite studies. The unilateral excitotoxic lesion was performed by injection ofα-amino-3-hydroxy-5-methylisoxazole-4-propionic acid unilaterally into the striatum. The striatum lesion was confirmed and correlated with TSPO expression in astrocytes and activated microglia by immunohistochemistry and autoradiography.In vivostudies with [123I]-CLINME indicated a biodistribution pattern consistent with TPSO distribution and the competition studies with PK11195 and Ro 5-4864 showed that [123I]-CLINME is selective for this site. The metabolite study showed that the extractable radioactivity was unchanged [123I]-CLINME in organs which expresses TSPO. SPECT/CT imaging on the unilateral excitotoxic lesion indicated that the mean ratio uptake in striatum (lesion : nonlesion) was 2.2. Moreover, TSPO changes observed by SPECT imaging were confirmed by immunofluorescence, immunochemistry, and autoradiography. These results indicated that [123I]-CLINME is a promising candidate for the quantification and visualization of TPSO expression in activated astroglia using SPECT.

scholarly journals Rationale for Processing of a Mg-Zn-Ca Alloy by Equal-Channel Angular Pressing for Use in Biodegradable Implants for Osteoreconstruction

Crystals ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 1381
Author(s):  
Natalia S. Martynenko ◽  
Natalia Yu. Anisimova ◽  
Olga V. Rybalchenko ◽  
Mikhail V. Kiselevskiy ◽  
Georgy Rybalchenko ◽  
...  
Keyword(s):  
Equal Channel Angular Pressing ◽  
Stromal Cells ◽  
Orthopedic Implants ◽  
Biodegradable Implants ◽  
Promising Candidate ◽  
Human Mesenchymal Stromal Cells ◽  
Angular Pressing ◽  
Cell Adhesion And Proliferation ◽  
Stimulation Of

Widespread use of Mg-Zn-Ca alloys in clinical orthopedic practice requires improvement of their mechanical properties—in particular, ductility—and enhancement of their bioactivity for accelerated osteoreconstruction. The alloy was studied in two structural states: after homogenization and after equal-channel angular pressing. Immersion and potentiodynamic polarization tests showed that the corrosion rate of the alloy was not increased by deformation. The mass loss in vivo was also statistically insignificant. Furthermore, it was found that deformation did not compromise the biocompatibility of the alloy and did not have any significant effect on cell adhesion and proliferation. However, an extract of the alloy promoted the alkaline phosphatase activity of human mesenchymal stromal cells, which indicates osteogenic stimulation of cells. The osteoinduction of the deformed alloy significantly exceeded that of the homogenized one. Based on the results of this work, it can be concluded that the alloy Mg-1%Zn-0.3%Ca modified by equal-channel angular pressing is a promising candidate for the manufacture of biodegradable orthopedic implants since it stimulates osteogenic differentiation and has greater ductility, which provides it with a competitive advantage in comparison with the homogenized state.

scholarly journals Relative contribution of non-structural protein 1 in dengue pathogenesis

2020 ◽  
Author(s):  
Pei Xuan Lee ◽  
Donald Heng Rong Ting ◽  
Clement Peng Hee Boey ◽  
Eunice Tze Xin Tan ◽  
Janice Zuo Hui Chia ◽  
...  
Keyword(s):  
Critical Role ◽  
Health Concern ◽  
Structural Protein ◽  
Promising Candidate ◽  
Relative Contribution ◽  
Structural Region ◽  
Strain Dependent ◽  
Pro Inflammatory Cytokines

AbstractDengue is a major public health concern in the tropical and sub-tropical world with no effective treatment. The controversial live attenuated virus vaccine Dengvaxia has boosted the pursuit of sub-unit vaccine approaches, and the non-structural protein 1 (NS1) has recently emerged as a promising candidate. However, we found that NS1 immunization or passive transfer of NS1 antibodies failed to confer protection in symptomatic dengue mouse models using two non mouse-adapted DENV2 strains from the Cosmopolitan genotype that currently circulates in South-East Asia. Furthermore, exogenous administration of purified NS1 did not worsen in vivo vascular leakage in sub-lethally infected mice, thereby supporting that NS1 does not play a critical role in the pathogenesis of these DENV2 strains. Virus chimerization approaches indicated that the prME structural region, but not NS1, plays a critical role in driving in vivo fitness and virulence of the virus, through induction of key pro-inflammatory cytokines. This work highlights that the pathogenic role of NS1 is DENV strain-dependent, which warrants re-evaluation of NS1 as a universal dengue vaccine candidate.

scholarly journals Development of the First Aliphatic 18F-Labeled Tetrazine Suitable for Pretargeted PET Imaging – Expanding the Bioorthogonal Tool Box

2021 ◽  
Author(s):  
Umberto Maria Battisti ◽  
Klas Bratteby ◽  
Jesper Tranekjær Jørgensen ◽  
Lars Hvass ◽  
Vladimir Shalgunov ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Blocking Effect ◽  
Structure Property ◽  
Promising Candidate ◽  
Bioorthogonal Reaction ◽  
Radiation Burden ◽  
Small Structure ◽  
Radiochemical Yields ◽  
State Of Art

<p>Pretargeting imaging of nanomedicines have attracted considerable interest in nuclear medicine since it has the potential to increase imaging contrast while simultaneously reducing radiation burden to healthy tissue. Currently, the tetrazine ligation is the fastest bioorthogonal reaction available for this strategy and consequently, the state-of-art choice for <i>in vivo</i>chemistry. We have recently identified key properties for tetrazines to be applied in pretargeting. We have also developed a method to <sup>18</sup>F-label highly reactive tetrazines using an aliphatic nucleophilic substitution strategy.<a> In this study, we combined this knowledge and developed an <sup>18</sup>F-labeled tetrazine for pretargeted imaging. In order to develop this ligand, a small structure-property study was carried out. The most promising compound - with respect to reactivity, hydrophilicity and <i>ex vivo</i> blocking effect - was selected for labeling and subsequent PET <i>in vivo</i> imaging. Radiolabeling was achieved in satisfying radiochemical yields, molar activities as well as in high radiochemical purities. The tracer </a><a>displayed favorable pharmacokinetics and remarkable target-to-background ratios in pretargeted experiments - already one hour post injection.</a> We believe that the developed pretargeting imaging agent is a promising candidate for translation into clinical studies.</p>

scholarly journals Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers

Acta Naturae ◽  
2015 ◽  
Vol 7 (4) ◽  
pp. 136-141 ◽  
Author(s):  
S. S. Terekhov ◽  
I. V. Smirnov ◽  
O. G. Shamborant ◽  
T. V. Bobik ◽  
D. G. Ilyushin ◽  
...  
Keyword(s):  
Broad Spectrum ◽  
Large Scale ◽  
Promising Candidate ◽  
Protective Index ◽  
Polysialic Acids ◽  
Long Acting ◽  
Nerve System ◽  
Molecular Compounds ◽  
Human Butyrylcholinesterase

Organophosphate toxins (OPs) are the most toxic low-molecular compounds. The extremely potent toxicity of OPs is determined by their specificity toward the nerve system. Human butyrylcholinesterase (hBChE) is a natural bioscavenger against a broad spectrum of OPs, which makes it a promising candidate for the development of DNA-encoded bioscavengers. The high values of the protective index observed for recombinant hBChE (rhBChE) make it appropriate for therapy against OP poisoning, especially in the case of highly toxic warfare nerve agents. Nevertheless, large-scale application of biopharmaceuticals based on hBChE is restricted due to its high cost and extremely rapid elimination from the bloodstream. In the present study, we examine two approaches for long-acting rhBChE production: I) chemical polysialylation and II) in-vivo tetramerization. We demonstrate that both approaches significantly improve the pharmacokinetic characteristics of rhBChE (more than 5 and 10 times, respectively), which makes it possible to use rhBChE conjugated with polysialic acids (rhBChE-CAO) and tetrameric rhBChE (4rhBChE) in the treatment of OP poisonings.

Melt Processed Polymer Blends for Potential Regenerative Medicine Applications

2014 ◽  
Vol 679 ◽  
pp. 92-100
Author(s):  
Elaine Kenny ◽  
Declan M. Devine ◽  
Clement L. Higginbotham ◽  
Luke M. Geever
Keyword(s):  
Molecular Weight ◽  
Differential Scanning Calorimetry ◽  
Regenerative Medicine ◽  
Polyethylene Oxide ◽  
Melt Flow Index ◽  
Flow Index ◽  
Biodegradable Implants ◽  
Scanning Calorimetry ◽  
Breakdown Rate

There is an urgent and unmet requirement for biocompatible and biodegradable implants that gradually resorb when implanted in vivo. This study examines the potential of melt extruded thermoplastics polyethylene oxide (PEO) and polycaprolactone (PCL) in the area of regenerative medicine. Various ratios of PEO and PCL were melt blended and analysed in order to obtain an optimised breakdown rate. Subsequently the effect of varying the molecular weight of PCL using a constant molecular weight PEO was also examined. Samples were characterised using melt flow index (MFI), differential scanning calorimetry (DSC) and breakdown analysis. It was found that by altering both the concentrations of PEO/PCL and the molecular weight of PCL, melt viscosity, breakdown rate and thermal properties could be modulated to produce potential implant materials with a tailored breakdown rate.

Glutathione-responsive PLGA nanocomplex for dual delivery of doxorubicin and curcumin to overcome tumor multidrug resistance

Nanomedicine ◽  
2021 ◽  
Author(s):  
Xuandi Lai ◽  
Xinran Geng ◽  
Mengqing Li ◽  
Mengxiong Tang ◽  
Qiong Liu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Multidrug Resistance ◽  
Blood Circulation ◽  
Release Profile ◽  
Drug Release Profile ◽  
Promising Candidate ◽  
Nano Drug Delivery ◽  
Mdr Reversal

Aim: This work aims to develop an injectable nano-drug delivery system to overcome tumor multidrug resistance (MDR). Methods: A drug delivery nanoplatform based on PEGylated PLGA with glutathione (GSH) responsivity was constructed for dual delivery of doxorubicin and curcumin (termed DCNP), and its MDR reversal efficiency was studied in vitro and in vivo. Results: The DCNPs exhibited a rapid drug release profile under high GSH concentration and could enhance the cellular uptake and cytotoxicity of doxorubicin to MDR cancer cells. Moreover, the DCNPs showed better biocompatibility, longer blood circulation and enhanced antitumor efficiency compared with free drugs. Conclusion: The GSH-responsive nanocarrier is believed to be a promising candidate for overcoming tumor MDR.

Sign in / Sign up

Export Citation Format

Share Document